Recently, the new crown specific drug s-217622 (its internal R & D number) of yanyeyi pharmaceutical in Japan has attracted great attention. It is reported that its cure rate has reached 100%. Is it really that divine? In fact, the company started the phase 1 clinical trial of the new crown specific drug s-217622 as early as last July, mainly in Japan. Up to now, s-217622 has completed phase 2A clinical trial, and phase 2B clinical trial is still analyzing data. According to the information r...

Recently, the new crown specific drug s-217622 (its internal R & D number) of yanyeyi pharmaceutical in Japan has attracted great attention. It is reported that its cure rate has reached 100%. Is it really that divine? In fact, the company started the phase 1 clinical trial of the new crown specific drug s-217622 as early as last July, mainly in Japan. Up to now, s-217622 has completed phase 2A clinical trial, and phase 2B clinical trial is still analyzing data. According to the information r...

Sina statement: Sina’s posting of this article for the purpose of transmitting more information does not mean that it agrees with its views or confirms its description. Wonderful recommendation Relevant news CGWR China game weight rank is the most comprehensive, professional, fair and objective multi platform game evaluation ranking list launched by Sina games. It includes all mobile games, end games, host games, VR games, smart TV games and H5 games in the current market, trying to create th...

Sina statement: Sina’s posting of this article for the purpose of transmitting more information does not mean that it agrees with its views or confirms its description. Wonderful recommendation Relevant news CGWR China game weight rank is the most comprehensive, professional, fair and objective multi platform game evaluation ranking list launched by Sina games. It includes all mobile games, end games, host games, VR games, smart TV games and H5 games in the current market, trying to create th...